Results - Announcements
FDC Ltd share price inched up 2.36% to Rs 353.95. The Company's net profit plunged by 62.97% to Rs 49.06 crore, while revenue from operations reduced 14.31% to Rs 572.14 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, rising 4.06%. It has marginally improved by 3.17% over last one week and eased lower by 0.26% in last one month while the market capitalization of FDC Ltd has improved by 4.23% and 12.84% in the same period respectively.
Profit before tax (PBT) of FDC Ltd stood at Rs 65.41 crore in Q3 FY26, surging by 71.72% year-on-year, and tanking 62.56% quarter-on-quarter. EBITDA came in at Rs 46 crore, rallying 251.67% YoY and crashing by 51.38% sequentially.
Total expenses marginally dropped 2.96% to Rs 523.83 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 139.94 crore, slightly declining by 3.16% YoY, while employee benefits expense was at Rs 134.28 crore, registering a marginal contraction of 0.65% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 2.98% to Rs 2170.93 crore, while net profit saw a marginal increase of 5.48% to Rs 281.42 crore, compared to previous TTM. EBITDA surged by 23865% to Rs 232.58 crore, and PBT saw a minor gain of 4.87% to Rs 374.6 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 200.45 crore in FY26, as against Rs 317.57 crore in FY25.
FDC Ltd crashed 18.08% in last one year, significantly underperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.